-

Human Factors and Usability Engineering in the Development of Drug Delivery Products - Two-Day Workshop Equips Product Developers with Human Factors Testing Skills (September 16-17, 2025) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Human Factors and Usability Engineering in the Development of Drug Delivery Products Training Course (ONLINE EVENT: September 16-17, 2025)" has been added to ResearchAndMarkets.com's offering.

This two-day workshop has been designed specifically for product developers who want to incorporate human factors testing into their product development or need to provide the regulators with specific usability data for their device to comply with the MDR.

The format for the day will be interactive with the presenter sharing his experiences as a specialist with extensive knowledge and understanding of the requirements of the MDR, IEC 62366 and FDA human factors Guidance. There will be questions posed for discussion and delegates will work through some of the key aspects of performing a successful human factors study.

Benefits of attending include:

  • Understand the requirements of IEC 62366 and FDA human factors Guidance
  • Know how to provide the regulators with specific usability data for your device
  • Understand human factors and the design process
  • Learn how to validate combination products
  • Consider human factors and risk
  • Discuss generic combination products - ANDAs and HF
  • Find out what HF data FDA require for biosimilars

Certifications:

  • CPD: 12 hours for your records
  • Certificate of completion

Who Should Attend:

This event will be beneficial to those working in the following areas:

  • Engineering and device development
  • Packaging
  • Regulatory affairs
  • Quality systems
  • Quality assurance
  • Risk management
  • Marketing
  • Usability and human factors engineering

Course Agenda

Introduction

  • Scope of the training
  • Expectations for the training

Background to human factors

  • Human factors, usability and ergonomics defined
  • Trends in drug delivery device technology
  • Use errors - scale, scope and implications
  • Defining the user interface
  • Usability research, clinical research and market research compared

Legal and regulatory requirements

  • US law and design control - implications for HF
  • MDR and usability requirements
  • Article 117 and implications for combination products
  • UK medical device regulations

IEC62366, FDA guidance and expectations

  • IEC62366 usability engineering process
  • FDA human factors guidance
  • ISO14971 applied to combination products
  • EMA guidance on combination products
  • Chinese human factors guidance 2022

Human factors methods and best practices

  • Human factors engineering
  • Perception, cognition and action model
  • Heuristic analysis

Design control, design and development

  • Design and development planning
  • Role of human factors in design control
  • UE methods and outputs
  • UE integration with combination product development

User needs & user interface specifications

  • Regulatory requirements for user needs
  • Defining formal user needs
  • User requirements and the design trace matrix
  • Building a user interface specification

Formative and validation testing methods

  • Formative testing methods
  • Human factors validation methods

Use-related risk

  • Regulatory requirements for use-related risk
  • ISO14971 applied to combination products
  • Risk analysis methods
  • Risk control
  • Residual risk analysis

HF and clinical trials

  • How HF and clinical trials differ
  • How to gather HF data during clinical trials
  • Changing the user interface during the trial program
  • HF requirements for INDs and IDEs

Technical data requirements

  • HF contents of a design history file
  • HF contents of a EU technical file

Predicate devices, platform devices and post-market surveillance

  • Platform devices - how to incorporate HF
  • Platform device due diligence
  • Post-market HF requirements - US and EU

Generic devices, biosimilars and ANDAs

  • How to do a database and literature search for known use problems
  • ANDA submissions and HF
  • ANDA versus 505(b)(2) HF requirements
  • FDA HF requirements for biosimilars

Practicalities - how to stay legal

  • GDPR, IRB, HIPAA and the Sunshine Act
  • When to apply for ethics/IRB approval
  • Common GDPR problems during HF testing

Wrap-up

  • Common pitfalls and top tips
  • Top tips

For more information about this training visit https://www.researchandmarkets.com/r/ii02pg

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

ENT Disorder Treatment: Global Market Trends, Regional Outlook and Growth Forecast 2025-2032 - Surge in Reimbursement Approvals for Novel Biologics Treating Severe Allergic & Chronic Sinusitis - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "ENT Disorder Treatment Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering. The ENT disorder treatment market is experiencing rapid transformation as organizations adopt new medical technologies and evolving care models to address complex clinical and operational challenges. Senior decision-makers are seeking strategies that enable both enhanced patient outcomes and sustainable organizational performance in this dynamic he...

Thyroid Eye Disease (TED) Treatments Market Nears $4.3 Billion by 2032: Emerging Small Molecule Therapies Targeting Orbital Fibroblasts Drive Revenue Growth - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Thyroid Eye Disease Treatments Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering. The thyroid eye disease treatments market is undergoing substantial transformation, fueled by new therapies, advanced diagnostics, and evolving care pathways. As a complex autoimmune disorder, thyroid eye disease challenges health systems and presents significant opportunities for innovation and patient-centered solutions. Market Snapshot:...

Electric Vehicles Battery Recycling Market Trends and Competition Analysis, 2025-2032 - Investment in Direct Cathode Recycling Methods are Reducing Energy Consumption and Waste - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Electric Vehicles Battery Recycling Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering. As stakeholders across the mobility sector pursue sustainability, the electric vehicles battery recycling market is quickly gaining prominence, driven by regulatory, economic, and technological imperatives. Senior decision-makers require actionable insights to navigate evolving policy, emerging partnerships, and investment priorities....
Back to Newsroom